| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TherapeuticsMD, Inc. | CEO, Director | Common Stock | 18M | $40.3M | $2.24 | May 11, 2021 | Direct |
| TherapeuticsMD, Inc. | CEO, Director | Common Stock | 2M | $4.48M | $2.24 | May 10, 2021 | Indirect |
| TherapeuticsMD, Inc. | CEO, Director | Restricted Stock Units | 747K | $2.72M | $3.64 | Jul 1, 2021 | Direct |
| TherapeuticsMD, Inc. | CEO, Director | Performance Stock Units | 1.49M | $2.59M | $1.73 | Jul 1, 2021 | Direct |
| ZyVersa Therapeutics, Inc. | Director | Stock Options | 11.1K | Jul 11, 2025 | Direct | ||
| ZyVersa Therapeutics, Inc. | Director | Stock Options | 132 | May 24, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. | Jul 11, 2025 | 1 | $0 | 4 | Jul 15, 2025 | Director |
| ZVSA | ZyVersa Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | Jul 18, 2024 | Director |
| ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 3 | $0 | 4 | Dec 14, 2022 | Director |
| ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 0 | $0 | 3 | Dec 13, 2022 | Director |
| TXMD | TherapeuticsMD, Inc. | Jul 1, 2021 | 2 | $0 | 4 | Jul 2, 2021 | CEO, Director |
| TXMD | TherapeuticsMD, Inc. | May 10, 2021 | 3 | -$70.4K | 4 | May 12, 2021 | CEO, Director |